UNICHEMLAB — Unichem Laboratories Income Statement
0.000.00%
- IN₹49.56bn
- IN₹50.58bn
- IN₹17.05bn
- 52
- 12
- 90
- 52
Annual income statement for Unichem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11,037 | 12,351 | 12,698 | 13,430 | 17,049 |
Cost of Revenue | |||||
Gross Profit | 6,209 | 7,649 | 7,512 | 6,698 | 9,331 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 12,347 | 12,279 | 12,831 | 15,356 | 17,787 |
Operating Profit | -1,310 | 72.8 | -133 | -1,925 | -738 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -482 | 515 | 220 | -1,764 | -617 |
Provision for Income Taxes | |||||
Net Income After Taxes | -602 | 343 | 331 | -2,022 | -705 |
Net Income Before Extraordinary Items | |||||
Net Income | -602 | 343 | 331 | -2,022 | -705 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -602 | 343 | 331 | -2,022 | -705 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -8.34 | 4.92 | 4.92 | -25.4 | -4.84 |
Dividends per Share |